These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23296924)

  • 21. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetically modified mRNA for efficient and fast human iPS cell generation and direct transdifferentiation to myoblasts.
    Preskey D; Allison TF; Jones M; Mamchaoui K; Unger C
    Biochem Biophys Res Commun; 2016 May; 473(3):743-51. PubMed ID: 26449459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells.
    Naota H; Miyahara Y; Okumura S; Kuzushima K; Akatsuka Y; Hiasa A; Kitano S; Takahashi T; Yuta A; Majima Y; Shiku H
    J Immunol Methods; 2006 Jul; 314(1-2):54-66. PubMed ID: 16828790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.
    Steinle H; Behring A; Schlensak C; Wendel HP; Avci-Adali M
    Stem Cells; 2017 Jan; 35(1):68-79. PubMed ID: 27250673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
    Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
    Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PiggyBac toolbox.
    Di Matteo M; Mátrai J; Belay E; Firdissa T; Vandendriessche T; Chuah MK
    Methods Mol Biol; 2012; 859():241-54. PubMed ID: 22367876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells.
    Tsai SY; Bouwman BA; Ang YS; Kim SJ; Lee DF; Lemischka IR; Rendl M
    Stem Cells; 2011 Jun; 29(6):964-71. PubMed ID: 21563278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans.
    Ratech H; Denning S; Kaufman RE
    Cell Immunol; 1997 May; 177(2):109-18. PubMed ID: 9178637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
    Schrader CE; Stavnezer J; Kikutani H; Parker DC
    J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of natural cytotoxicity receptors NKp30, NKp44, and NKp46 mRNAs and proteins by human hematopoietic and non-hematopoietic cells.
    Srivastava BI; Srivastava MD
    Leuk Res; 2006 Jan; 30(1):37-46. PubMed ID: 16061284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.
    Nishimura T; Kaneko S; Kawana-Tachikawa A; Tajima Y; Goto H; Zhu D; Nakayama-Hosoya K; Iriguchi S; Uemura Y; Shimizu T; Takayama N; Yamada D; Nishimura K; Ohtaka M; Watanabe N; Takahashi S; Iwamoto A; Koseki H; Nakanishi M; Eto K; Nakauchi H
    Cell Stem Cell; 2013 Jan; 12(1):114-26. PubMed ID: 23290140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Derivation of induced pluripotent stem cells from human peripheral circulating T cells.
    Seki T; Yuasa S; Fukuda K
    Curr Protoc Stem Cell Biol; 2011 Sep; Chapter 4():Unit4A.3. PubMed ID: 21913170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential cytokine gene expression in CD4+ and CD8+ T cell subsets of calves.
    Tanaka S; Aso H; Miyazawa K; Nagai Y; Watanabe K; Ohwada S; Kobayashi J; Yamaguchi T
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):84-91. PubMed ID: 17543393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Assembly, Production, and Transfection of Synthetic Modified mRNA.
    Oh S; Kessler JA
    Methods; 2018 Jan; 133():29-43. PubMed ID: 29080741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine.
    Kwon H; Kim M; Seo Y; Moon YS; Lee HJ; Lee K; Lee H
    Biomaterials; 2018 Feb; 156():172-193. PubMed ID: 29197748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development. A stem cell perspective on cellular engineering.
    Doulatov S; Daley GQ
    Science; 2013 Nov; 342(6159):700-2. PubMed ID: 24202165
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences.
    Rhoads RE
    Methods Mol Biol; 2016; 1428():3-27. PubMed ID: 27236789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond.
    Vallazza B; Petri S; Poleganov MA; Eberle F; Kuhn AN; Sahin U
    Wiley Interdiscip Rev RNA; 2015; 6(5):471-99. PubMed ID: 26061157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.